Cui-Ying Mao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cui-Ying Mao has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Guo-Hui Liu
Department of Cardiology, China-Japan Union Hospital, Jilin University, Changchun, PR China
1 shared publicationHai-Bin Lu
College of Pharmacy, Jilin University, Changchun, PR China
1 shared publication- Haiqi Li
Department of Neurology, China-Japan Union Hospital, Jilin University, Changchun 130033, Jilin Province, China
1 shared publication Jin-Ting He
Department of Neurology, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China
1 shared publication- Jin-Ting He
Department of Neurology, China-Japan Union Hospital, Jilin University, Changchun 130033, Jilin Province, China
1 shared publication - Le Yang
Department of Endocrinology, The People's Hospital of Jilin Province, Changchun 130031, China
1 shared publication
Latest Publications
- 2 December 2019
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 73 (1) , 39-58
Vascular Risk Factors and Alzheimer’s Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links
Alzheimer’s disease (AD) is a neurodegenerative disorder, marked by cortical and hippocampal deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles and cognitive impairment. Studies indicate a prominent link between cerebrovascular abnormalities and the onset and progression of AD, where blood-brain barrier (BBB) dysfunction and metabolic disorders play key risk factors. Pericyte degeneration, endothelial cell damage, astrocyte depolarization, diminished tight junction integrity, and basement membrane disarray trigger BBB damage. Subsequently, the altered expression of low-density lipoprotein receptor-related protein 1 and receptor for advanced glycation end products at the microvascular endothelial cells dysregulate Aβ transport across the BBB. White matter lesions and microhemorrhages, dyslipidemia, altered brain insulin signaling, and insulin resistance contribute to tau and Aβ pathogenesis, and oxidative stress, mitochondrial damage, inflammation, and hypoperfusion serve as mechanistic links between pathophysiological features of AD and ischemia. Deregulated calcium homeostasis, voltage gated calcium channel functioning, and protein kinase C signaling are also common mechanisms for both AD pathogenesis and cerebrovascular abnormalities. Additionally, APOE polymorphic alleles that characterize impaired cerebrovascular integrity function as primary genetic determinants of AD. Overall, the current review enlightens key vascular risk factors for AD and underscores pathophysiologic relationship between AD and vascular dysfunction.
- 2 December 2019
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 73 (1) , 39-58
Vascular Risk Factors and Alzheimer’s Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links
Alzheimer’s disease (AD) is a neurodegenerative disorder, marked by cortical and hippocampal deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles and cognitive impairment. Studies indicate a prominent link between cerebrovascular abnormalities and the onset and progression of AD, where blood-brain barrier (BBB) dysfunction and metabolic disorders play key risk factors. Pericyte degeneration, endothelial cell damage, astrocyte depolarization, diminished tight junction integrity, and basement membrane disarray trigger BBB damage. Subsequently, the altered expression of low-density lipoprotein receptor-related protein 1 and receptor for advanced glycation end products at the microvascular endothelial cells dysregulate Aβ transport across the BBB. White matter lesions and microhemorrhages, dyslipidemia, altered brain insulin signaling, and insulin resistance contribute to tau and Aβ pathogenesis, and oxidative stress, mitochondrial damage, inflammation, and hypoperfusion serve as mechanistic links between pathophysiological features of AD and ischemia. Deregulated calcium homeostasis, voltage gated calcium channel functioning, and protein kinase C signaling are also common mechanisms for both AD pathogenesis and cerebrovascular abnormalities. Additionally, APOE polymorphic alleles that characterize impaired cerebrovascular integrity function as primary genetic determinants of AD. Overall, the current review enlightens key vascular risk factors for AD and underscores pathophysiologic relationship between AD and vascular dysfunction.
- 1 April 2019
- Published by Elsevier in European Journal of Pharmacology
- Vol. 849, 146-153
Role of hydrogen sulfide in cognitive deficits: Evidences and mechanisms
- 1 April 2019
- Published by Elsevier in European Journal of Pharmacology
- Vol. 849, 146-153
Role of hydrogen sulfide in cognitive deficits: Evidences and mechanisms